Diabetes Management Stocks List

Diabetes Management Stocks Recent News

Date Stock Title
May 8 PODD Insulet Q1 2024 Earnings Preview
May 8 TNDM Tandem insulin pump error leads to FDA Class I recall
May 8 INBS Intelligent Bio Solutions GAAP EPS of -$1.43 misses by $0.56, revenue of $0.82M misses by $0.37M
May 8 INBS Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights
May 7 PODD Wolfe raises Insulet to outperform, cites increasing market share
May 7 PODD Insulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth
May 6 PODD Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
May 6 PODD Gear Up for Insulet (PODD) Q1 Earnings: Wall Street Estimates for Key Metrics
May 5 TNDM Earnings Update: Here's Why Analysts Just Lifted Their Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Price Target To US$43.57
May 3 TNDM Why Tandem Diabetes Stock Just Jumped 22%
May 3 TNDM Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call Transcript
May 3 TNDM Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday
May 3 TNDM Tandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises '24 View
May 3 TNDM Q1 2024 Tandem Diabetes Care Inc Earnings Call
May 3 TNDM Tandem Diabetes Care Inc (TNDM) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
May 3 TNDM Tandem Diabetes Care, Inc. (TNDM) Q1 2024 Earnings Call Transcript
May 2 TNDM Tandem Diabetes Care (TNDM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
May 2 PODD Insulet (PODD) Rises Higher Than Market: Key Facts
May 2 TNDM Tandem Diabetes Care Inc (TNDM) Q1 2024 Earnings: Outperforms Revenue Estimates and Updates ...
May 2 TNDM Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
Diabetes Management

The term diabetes includes several different metabolic disorders that all, if left untreated, result in abnormally high concentration of a sugar called glucose in the blood. Diabetes mellitus type 1 results when the pancreas no longer produces significant amounts of the hormone insulin, usually owing to the autoimmune destruction of the insulin-producing beta cells of the pancreas. Diabetes mellitus type 2, in contrast, is now thought to result from autoimmune attacks on the pancreas and/or insulin resistance. The pancreas of a person with type 2 diabetes may be producing normal or even abnormally large amounts of insulin. Other forms of diabetes mellitus, such as the various forms of maturity onset diabetes of the young, may represent some combination of insufficient insulin production and insulin resistance. Some degree of insulin resistance may also be present in a person with type 1 diabetes.
The main goal of diabetes management is, as far as possible, to restore carbohydrate metabolism to a normal state. To achieve this goal, individuals with an absolute deficiency of insulin require insulin replacement therapy, which is given through injections or an insulin pump. Insulin resistance, in contrast, can be corrected by dietary modifications and exercise. Other goals of diabetes management are to prevent or treat the many complications that can result from the disease itself and from its treatment.

Browse All Tags